Latest filing published 17 Aug 2022 for Beijing Tong Ren Tang Chinese Medicine Co. Ltd., €23k. Read the official filing
Based on 7 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Ding Yong Ling discloses dealings in Beijing Tong Ren Tang Chinese Medicine Co. Ltd. to HKEX. In total, 7 filings cover trades dated from 27 April 2018 to 17 August 2022.
Purchases make up the whole of the open-market record (7 purchases, €215k). A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. So far in 2022, the count stands at 1 purchase and no sales.
A typical purchase (the median) is worth €24k. Of 7 purchases, 3 formed part of a group of insiders buying within 30 days of each other. A cluster is several different insiders buying the same stock within a short window, a pattern studied more closely than a single purchase. For 7 purchases whose 90-day window has closed, the share price was higher on day 90 than the day after publication in 71% of cases, with a median move of +8.6%. These figures describe past trades and do not predict future prices.
The record was last updated on 17 August 2022 with an open-market purchase (€23k) in Beijing Tong Ren Tang Chinese Medicine Co. Ltd. The median gap between trade and publication is zero days: most filings appear on the same day. This delay matters because a trade only becomes useful information once it is public. Source: insider filings from HKEX. Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
7 of 7 declarations